Tag: cancer
-
Gene-Edited Treatments in Works for Safer Cancer Therapies
A cancer center and biotechnology enterprise are developing gene-edited therapies working in the gut to reduce adverse effects from cancer immunotherapies.
-
Immunotherapy Biotech Gains $108M in New Funds
A company developing more precise immunotherapies for cancer and other diseases is raising $108 million in its second venture funding round.
-
Small Biz Grant to Advance Cancer Chemotherapy Patch
A medical device company is receiving a small business grant from NIH to commercialize a patch that delivers chemotherapy directly to oral tumors.
-
AI-Analyzed Liquid Biopsy IDs Early Lung Cancer
A blood test analyzed with algorithms is shown to detect more than 90 percent of early-stage lung cancer cases in people at high risk of the disease.
-
Liquid Biopsy Tech Adapted for Covid-19 Testing
A company developing non-invasive liquid biopsy tests for cancer received NIH funding to extend that technology for quick Covid-19 virus tests.
-
NIH Funds Programmable mRNA to Treat Cancer
National Cancer Institute is funding research on using programmable synthetic messenger RNA to treat two types of solid tumor cancer.
-
Immune Cell Cancer Biotech Gains $172M in New Funds
A biotechnology company developing cancer therapies with natural killer cells in the immune system is raising $172 million in its second venture round.
-
Trial Underway for Crispr Lymphoma Therapy
A clinical trial enrolled its first participant testing the safety of a treatment for lymphoma, a type of cancer, using the gene-editing technique Crispr.
-
Biotechs Partner on Lower Cost AI-Designed Drugs
Two biotechnology companies are collaborating on discovery and development of new drugs designed with artificial intelligence, at lower cost to patients.
-
Micro Brain Robot Granted Orphan Status
A tiny remote-controlled device that carries chemotherapy drugs to brain tumors received orphan drug status from the Food and Drug Administration.